Safety and efficacy of VRC01 broadly neutralising antibodies in adults with acutely treated HIV (RV397): a phase 2, randomised, double-blind, placebo-controlled trial

Trevor A. Crowell(Henry M. Jackson Foundation), Donn Colby(Thai Red Cross Society), Suteeraporn Pinyakorn(Walter Reed Army Institute of Research), Carlo Sacdalan(Thai Red Cross Society), Amélie Pagliuzza(Centre Hospitalier de l’Université de Montréal), Jintana Intasan(Thai Red Cross Society), Khunthalee Benjapornpong(Thai Red Cross Society), Kamonkan Tangnaree(Thai Red Cross Society), Nitiya Chomchey(Thai Red Cross Society), Eugène Kroon(Thai Red Cross Society), Mark de Souza(Henry M. Jackson Foundation), Sodsai Tovanabutra(Henry M. Jackson Foundation), Morgane Rolland(Walter Reed Army Institute of Research), Michael A. Eller(Walter Reed Army Institute of Research), Dominic Paquin‐Proulx(Walter Reed Army Institute of Research), Diane L. Bolton(Henry M. Jackson Foundation), Andrey Tokarev(Walter Reed Army Institute of Research), Rasmi Thomas(Henry M. Jackson Foundation), Hiroshi Takata(Walter Reed Army Institute of Research), Lydie Trautmann(Walter Reed Army Institute of Research), Shelly J. Krebs(Walter Reed Army Institute of Research), Kayvon Modjarrad(Walter Reed Army Institute of Research), Adrian B. McDermott(National Institutes of Health), Robert T. Bailer(National Institutes of Health), Nicole A. Doria‐Rose(National Institute of Allergy and Infectious Diseases), Bijal Patel(National Institutes of Health), Robert J. Gorelick(Frederick National Laboratory for Cancer Research), Brandie Fullmer(Frederick National Laboratory for Cancer Research), Alexandra Schuetz(Armed Forces Research Institute of Medical Science), Pornsuk V. Grandin(Armed Forces Research Institute of Medical Science), Robert J. O’Connell(Walter Reed Army Institute of Research), Julie E. Ledgerwood(National Institute of Allergy and Infectious Diseases), Barney S. Graham(National Institutes of Health), Randall Tressler(National Institutes of Health), John R. Mascola(National Institutes of Health), Nicolas Chomont(Centre Hospitalier de l’Université de Montréal), Nelson L. Michael(Walter Reed Army Institute of Research), Merlin L. Robb(Henry M. Jackson Foundation), Nittaya Phanuphak(Thai Red Cross Society), Jintanat Ananworanich(Thai Red Cross Society), Julie A. Ake(National Institute of Allergy and Infectious Diseases), Siriwat Akapirat, Meera Bose, Evan M. Cale, Phillip Chan, Sararut Chanthaburanun, Nampueng Churikanont, Peter Dawson, Netsiri Dumrongpisutikul, Saowanit Getchalarat, Surat Jongrakthaitae, Krisada Jongsakul, Sukalaya Lerdlum, Sopark Manasnayakorn, Corinne McCullough, Mark Milazzo(Henry M. Jackson Foundation), Bessara Nuntapinit, Kier On(Walter Reed Army Institute of Research), Madelaine Ouellette, Praphan Phanuphak(Thai Red Cross Society), Eric Sanders‐Buell, Nongluck Sangnoi, Shida Shangguan, Sunee Sirivichayakul, Nipattra Tragonlugsana, Rapee Trichavaroj, Sasiwimol Ubolyam, Sandhya Vasan, Phandee Wattanaboonyongcharoen, Thipvadee Yamchuenpong
The Lancet HIV
April 15, 2019
Cited by 104Open Access
Full Text

Abstract


Related Papers

No related papers found

Powered by citation graph analysis